Acro Biomedical (ACBM) Assets Average (2017 - 2025)
Acro Biomedical (ACBM) has 9 years of Assets Average data on record, last reported at $9210.5 in Q4 2025.
- For Q4 2025, Assets Average fell 73.93% year-over-year to $9210.5; the TTM value through Dec 2025 reached $9210.5, down 73.93%, while the annual FY2025 figure was $23036.0, 49.05% down from the prior year.
- Assets Average reached $9210.5 in Q4 2025 per ACBM's latest filing, down from $28800.0 in the prior quarter.
- Across five years, Assets Average topped out at $968463.5 in Q1 2021 and bottomed at $9210.5 in Q4 2025.
- Average Assets Average over 5 years is $389417.4, with a median of $438565.0 recorded in 2023.
- Peak YoY movement for Assets Average: decreased 0.75% in 2021, then tumbled 94.18% in 2023.
- A 5-year view of Assets Average shows it stood at $695452.5 in 2021, then fell by 4.3% to $665567.0 in 2022, then crashed by 94.18% to $38743.0 in 2023, then decreased by 8.82% to $35325.0 in 2024, then crashed by 73.93% to $9210.5 in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $9210.5 in Q4 2025, $28800.0 in Q3 2025, and $39226.0 in Q2 2025.